To learn more about us and our work on behalf of whistleblowers, please browse below for posts and articles we’ve drafted, as well as news about the Whistleblower Law Collaborative. For more general information on this area of the law, please visit Resources or follow us on social media.
October 2, 2020
The U.S. Attorney’s Office for the District of Massachusetts logged another victory in its battle against co-pay foundation kickback schemes. This time pharma giant Gilead Sciences is paying up to...September 14, 2020
The pharmaceutical company Indivior Solutions agreed to pay a total of $600 million to resolve opioid fraud charges involving the marketing its drug Suboxone. Indivior’s parent company, Reckitt Benckiser Group,...September 10, 2020
After a decade of teaching the popular Health Care Fraud and Abuse seminar at Boston University Law School, Whistleblower Law Collaborative LLC (“WLC”) Co-Founder Bob Thomas has started an additional...September 8, 2020
David Lieberman and Bruce Judge discussed the scourge of compounding fraud in New Jersey with The Press of Atlantic City. The article, South Jersey prescription fraud ring follows national playbook, concerns...September 2, 2020
Ethan P. Davis, the Principal Deputy Assistant Attorney General for DOJ’s Civil Division recently described how the Civil Division will approach COVID-19 fraud enforcement. His remarks follow Senate testimony in...August 27, 2020
The Massachusetts U.S. Attorney’s Office recently filed a health care fraud lawsuit against drug manufacturer Teva Pharmaceuticals (specifically, Teva Pharmaceuticals USA, Inc., and Teva Neuroscience, Inc.). The United States’ False...
